FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

AMA Wants to End Pay-for-Delay

[ Price : $8.95]

The American Medical Association calls for an end to pay-for-delay agreements that can slow the marketing of generic drugs.

FDA Clears Vital Images 3-D Medical Viewer

[ Price : $8.95]

FDA clears a Vital Images 510(k) for three-dimensional viewing and computer tablet viewing through its universal viewer VitreaView...

Enhanced Communication Team Works with Drug Sponsors

[ Price : $8.95]

FDA publishes a PDUFA notice on the work of the CDER enhanced communication team.

Forest, Ademas to Develop Fixed Dosed Alzheimers Treatment

[ Price : $8.95]

Forest Laboratories and Adamas Pharmaceuticals enter into an agreement to develop a fixed dosed combination of Namenda XR and done...

FDA Publishes Notice of FDA User Fee System Records

[ Price : $8.95]

Federal Register Notice: FDA publishes notice of a system of records entitled, FDA User Fee System, HHS/FDA.

Hamburg in Hot Seat at Drug Compounding Hearing

[ Price : $8.95]

Democratic senators and House Energy and Commerce Committee Republican members take aim at FDA in separate Hill hearings and criti...

FDA Rejects Xyrem ANDA Bioequivalence Request

[ Price : $8.95]

FDA denies a Jazz Pharmaceuticals citizen petition asking that it publish bioequivalence requirements for any ANDA for a generic f...

Hospira Holds Symbiq Pump Shipments

[ Price : $8.95]

Hospira tells the SEC it is suspending shipment of Symbiq infusion pumps to U.S. customers due to an FDA import alert.

Opana ER Reducing Abuse, Endo Says

[ Price : $8.95]

Endo tells FDA that its reformulated Opana ER has reduced opioid drug abuse.

FDA Clears Cerner FetaLink Surveillance System

[ Price : $8.95]

FDA clears a Cerner 510(k) for its FetaLink+, a solution that provides clinicians access to maternal and fetal surveillance inform...